Follow
Peverelli E
Peverelli E
Unknown affiliation
Verified email at unimi.it
Title
Cited by
Cited by
Year
Pseudohypoparathyroidism and GNAS Epigenetic Defects: Clinical Evaluation of Albright Hereditary Osteodystrophy and Molecular Analysis in 40 Patients
G Mantovani, L de Sanctis, AM Barbieri, FM Elli, V Bollati, V Vaira, ...
The Journal of Clinical Endocrinology & Metabolism 95 (2), 651-658, 2010
1802010
Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2
E Ferrante, C Pellegrini, S Bondioni, E Peverelli, M Locatelli, P Gelmini, ...
Endocrine-related cancer 13 (3), 955-962, 2006
1382006
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein
AG Lania, G Mantovani, S Ferrero, C Pellegrini, S Bondioni, E Peverelli, ...
Cancer research 64 (24), 9193-9198, 2004
1022004
Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas
CL Ronchi, E Peverelli, S Herterich, I Weigand, G Mantovani, ...
European journal of endocrinology 174 (3), 363-372, 2016
1012016
Protective effect of TAT‐delivered α‐synuclein: relevance of the C‐terminal domain and involvement of HSP70
D Albani, E Peverelli, R Rametta, S Batelli, L Veschini, A Negro, G Forloni
The FASEB journal 18 (14), 1713-1715, 2004
1002004
Autosomal Dominant Pseudohypoparathyroidism Type Ib: A Novel Inherited Deletion Ablating STX16 Causes Loss of Imprinting at the A/B DMR
FM Elli, L de Sanctis, E Peverelli, P Bordogna, B Pivetta, G Miolo, ...
The Journal of Clinical Endocrinology & Metabolism 99 (4), E724-E728, 2014
752014
Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs
E Peverelli, G Mantovani, E Vitali, FM Elli, L Olgiati, S Ferrero, ER Laws, ...
The Journal of Clinical Endocrinology & Metabolism 97 (3), 967-977, 2012
682012
cAMP in the pituitary: an old messenger for multiple signals
E Peverelli, G Mantovani, AG Lania, A Spada
J Mol Endocrinol 52 (1), R67-77, 2014
642014
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells
G Mantovani, S Bondioni, AG Lania, M Rodolfo, E Peverelli, N Polentarutti, ...
Oncogene 27 (13), 1834-1843, 2008
632008
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations
ML Jaffrain-Rea, S Rotondi, A Turchi, G Occhi, A Barlier, E Peverelli, ...
Endocrine-Related Cancer 20 (5), 753-766, 2013
612013
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations
FM Elli, L de Sanctis, V Bollati, L Tarantini, M Filopanti, AM Barbieri, ...
The Journal of Clinical Endocrinology & Metabolism 99 (3), E508-E517, 2014
582014
The dopamine–somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 …
E Peverelli, L Olgiati, M Locatelli, P Magni, MF Fustini, G Frank, ...
Cancer letters 288 (2), 170-176, 2010
542010
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from …
E Peverelli, E Giardino, D Treppiedi, M Meregalli, M Belicchi, V Vaira, ...
International journal of cancer 140 (8), 1870-1880, 2017
532017
The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation
E Peverelli, G Mantovani, D Calebiro, A Doni, S Bondioni, A Lania, ...
Molecular endocrinology 22 (3), 676-688, 2008
532008
Filamin A (FLNA) plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells
E Peverelli, E Giardino, D Treppiedi, E Vitali, V Cambiaghi, M Locatelli, ...
Endocrinology 155 (8), 2932-2941, 2014
522014
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation
AG Lania, S Ferrero, R Pivonello, G Mantovani, E Peverelli, A Di Sarno, ...
The Journal of Clinical Endocrinology & Metabolism 95 (1), 13-17, 2010
512010
Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation
G Mantovani, AG Lania, S Bondioni, E Peverelli, C Pedroni, S Ferrero, ...
Experimental cell research 314 (1), 123-130, 2008
502008
Dopamine and somatostatin analogues resistance of pituitary tumors: focus on cytoskeleton involvement
E Peverelli, D Treppiedi, E Giardino, E Vitali, AG Lania, G Mantovani
Frontiers in Endocrinology 6, 175581, 2015
472015
Cyclic adenosine 3′-5′-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent …
E Vitali, E Peverelli, E Giardino, M Locatelli, GB Lasio, P Beck-Peccoz, ...
Molecular and cellular endocrinology 383 (1-2), 193-202, 2014
442014
Effect of cyclic adenosine 3′, 5′-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas
G Mantovani, S Bondioni, S Ferrero, B Gamba, E Ferrante, E Peverelli, ...
The Journal of Clinical Endocrinology & Metabolism 90 (12), 6721-6724, 2005
402005
The system can't perform the operation now. Try again later.
Articles 1–20